NeuroVision announces a $15 million Series C financing with a first close of $11.2 million

(Public Relations Pacific LLC) NeuroVision Imaging Inc. has announced a Series C financing round of $15 million with an initial close of $11.2 million. The round is led by Wildcat Capital Management with funding from several new investment groups. The financing provides support for NeuroVision as it seeks validation and regulatory approval for its breakthrough, low-cost, noninvasive, eye imaging system for measuring retinal autofluorescence that can detect amyloid beta (Aβ) plaque in the eye.
Source: EurekAlert! - Biology - Category: Biology Source Type: news